Centre hospitalier universitaire Pellegrin

Bordeaux 33076

0 studies enrolling now · 3 studies all time

What they study most

Plaque Psoriasis, Systemic Lupus Erythematosus

Studies at this site

• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) — Completed
• Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis — Completed